mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 645, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-03-29
DOI
10.1126/scitranslmed.abm2311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
- (2022) Paulina Kaplonek et al. IMMUNITY
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Discrete SARS-CoV-2 antibody titers track with functional humoral stability
- (2021) Yannic C. Bartsch et al. Nature Communications
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
- (2021) Linde Schoenmaker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
- (2021) Ai-ris Y. Collier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
- (2021) Dan Frampton et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351
- (2021) Nisha Bhattarai et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamics of SARS-CoV-2 with waning immunity in the UK population
- (2021) Thomas Crellen et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Human IgG and IgA responses to COVID-19 mRNA vaccines
- (2021) Adam V. Wisnewski et al. PLoS One
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects
- (2021) Michelle Meyer et al. Science Translational Medicine
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
- (2021) Paulina Kaplonek et al. Science Immunology
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
- (2021) Patrick Tang et al. NATURE MEDICINE
- Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
- (2021) Barbra A. Dickerman et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women
- (2021) Caroline Atyeo et al. Science Translational Medicine
- Epidemiological and Immunological Features of Obesity and SARS-CoV-2
- (2021) Eric J. Nilles et al. Viruses-Basel
- Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
- (2021) F. Abdullah et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
- (2020) Caroline Atyeo et al. IMMUNITY
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination
- (2020) Todd J. Suscovich et al. Science Translational Medicine
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
- (2020) Lisa H. Tostanoski et al. NATURE MEDICINE
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
- (2020) Jee-Soo Lee et al. CLINICAL INFECTIOUS DISEASES
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- A versatile high throughput assay to characterize antibody-mediated neutrophil phagocytosis
- (2019) Christina B. Karsten et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Fc Glycan-Mediated Regulation of Placental Antibody Transfer
- (2019) Madeleine F. Jennewein et al. CELL
- A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation
- (2019) Stephanie Fischinger et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials
- (2019) Philip K. Ehrenberg et al. Science Translational Medicine
- A Sample-Sparing Multiplexed ADCP Assay
- (2019) Audrey L. Butler et al. Frontiers in Immunology
- Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
- (2017) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses
- (2015) Etienne A. Thévenot et al. JOURNAL OF PROTEOME RESEARCH
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
- (2014) Stylianos Bournazos et al. JOURNAL OF CLINICAL INVESTIGATION
- High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
- (2012) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started